MPI Policy

The Management of Medical Precision Implants, S.A. (hereinafter MPI) has established a policy in line with the previously defined vision and strategy. It provides a framework for setting and reviewing business objectives – which are periodically reviewed by Management, who ensures the availability of the necessary resources for their achievement and the maintenance of the system.

MPI is a company in the dental sector dedicated to the design, development, manufacture and sale of dental implant systems, prosthetic components and surgical instruments; to the import of anchorage systems for implant-supported overdentures; and to the import of artificial bone.

As part of the continuous improvement process, and to ensure the management of innovation and quality in product design, an Integrated Quality and R&D&I Management System (hereinafter SGI), which ensures compliance with the applicable legal and regulatory requirements set out in Regulation 2017/745 and Royal Decree 192/2023 governing medical devices, with the aim of achieving customer satisfaction and that of other interested parties, and maintaining the effectiveness of the implemented system.

MPI is certified to ISO 13485:2016 to ensure the Management System is implemented and to UNE 166002:2021 to validate the effectiveness of R&D&I projects. Audits are carried out annually by a Certification Body and a Notified Body to ensure compliance with the requirements of the standards.

Management conducts an annual review of the established policy to ensure that it is implemented and maintained. It communicates this policy internally – to all MPI employees – and ensures that everyone understands it.

This policy is available as documented information within MPI’s QMS and is accessible; to enhance MPI’s reputation and engage relevant stakeholders, it is made available to all interested parties upon request.

Madrid, 4 September 2025

Version: 4